Treace Medical Concepts (TMCI) Short-term Investments (2022 - 2026)

Treace Medical Concepts (TMCI) has reported Short-term Investments for 5 consecutive years, with $33.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Short-term Investments fell 46.1% year-over-year to $33.0 million; the trailing twelve-month figure through Jun 2026 stood at $33.0 million (down 46.1% YoY), and the FY2025 full-year result was $37.7 million, down 41.46% from the prior year.
• Short-term Investments retreated to $33.0 million in Q2 2026 per TMCI's latest filing, from $42.3 million in the prior quarter.
• Across five years, Short-term Investments topped out at $141.0 million in Q1 2023 and bottomed at $33.0 million in Q2 2026.
• Historically, Short-term Investments has averaged $77.0 million across 5 years, with a median of $64.3 million in 2024.
• The sharpest annual moves came in 2023 and 2026: Short-term Investments surged 78.4% in 2023, then sank 46.1% in 2026.
• Over 5 years, Short-term Investments stood at $61.8 million in 2022, then soared by 78.4% to $110.2 million in 2023, then tumbled by 41.64% to $64.3 million in 2024, then slumped by 41.46% to $37.7 million in 2025, then declined by 12.35% to $33.0 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $33.0 million, $42.3 million, and $37.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.